News
Panaxia sums up 2021 with a growth of 38% in total revenues of its Israeli activity, including initial revenues from cannabis oils export of 5.6 million
April 5, 2022 | BENZINGA – Net Israeli revenues in 2021 increased 38% to 83.6 million. – Initial revenues from medical cannabis oils export from Israel, which
Panaxia’s Malta Facility Granted EU-GMP Standard, Enabling Export Of Its Products Across Various EU Countries
January 3, 2022 | BENZINGA Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard
Israel: Medical cannabis, without the smoking health risks
December 15, 2021 | I24NEWS i24NEWSDecember 15, 2021, 08:58 PM latest revision December 15, 2021, 08:59 PM i24NEWSAnchor Jeff Smith (R) and Dr. Dadi Segal, Panaxia
Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales